On its agenda was the following item:
5.1 Pharmacy Compounding Practice. The board will discuss the scope of pharmacy practice in
compounding pharmaceutical products and consider a response to the Ther-Rx Corporation letter
reviewed at the September meeting. Information/Action
To view entire agenda click here
5.1 Pharmacy Compounding Practice. The board will discuss the scope of pharmacy practice in
compounding pharmaceutical products and consider a response to the Ther-Rx Corporation letter
reviewed at the September meeting. Information/Action
To view entire agenda click here
No comments:
Post a Comment